NeuBase Therapeutics Inc (FRA:O7P)
€ 0.3406 0 (0%) Market Cap: 1.30 Mil Enterprise Value: -5.35 Mil PE Ratio: 0 PB Ratio: 0.15 GF Score: 35/100

NeuBase Therapeutics Inc at Chardan Genetic Medicines Conference Transcript

Release Date Price: €7.16 (-4.28%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot